Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Effects of Apelin in Healthy Volunteers
NCT02259686Phase 1Completed
- Sponsor
- University of Edinburgh
- Start
- Nov 2014
- Primary completion
- May 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of Apelin in heart failure (HF) (3 arms), sponsored by University of Edinburgh. Primary endpoints: Change in cardiac output at 10 hours and Change in blood pressure at 10 hours. Started Nov 2014; status: completed.
02
Drugs
Apelin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02259686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259686.